NirvaMed is an early-stage medical device company pioneering a novel treatment for ST-Elevation Myocardial Infarction (STEMI) heart attacks designed to substantially reduce heart muscle death and redefine the standard of care.
Headquarters:
United States of America
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2019 (6 years)
Address:
8500 PILLSBURY AVE; MINNEAPOLIS, MINNESOTA, US
At a glanceLOW
spending power
